The DOI matches its Crossref record.
Thrombolytic Therapy of Pulmonary Embolism
Open accessAbstract
Pulmonary embolism (PE) is a common disorder that is accompanied by significant morbidity and mortality. Although anticoagulation is the standard treatment for PE, thrombolytic therapy, with its ability to produce rapid clot lysis, has long been considered an attractive alternative. Although many studies have been performed over the past three decades, however, the indications for the use of thrombolytic agents in patients with PE remain controversial. In this article, we review the medical literature and provide evidence-based guidelines for the use of thrombolytic therapy. We will also discuss the practical aspects of PE thrombolysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 102
- Coon, 1959, Deep venous thrombosis and pulmonary embolism: prediction, prevention and treatment, Am J Cardiol, 4, 611, 10.1016/0002-9149(59)90145-6 · doi:10.1016/0002-9149(59)90145-6
- Dalen, 1975, Natural history of pulmonary embolism, Prog Cardiovasc Dis, 17, 259, 10.1016/S0033-0620(75)80017-X · DOI · Paper page
- Bell, 1982, Current status of pulmonary thromboembolic disease: pathophysiology, diagnosis, prevention and treatment, Am Heart J, 103, 239, 10.1016/0002-8703(82)90498-7 · doi:10.1016/0002-8703(82)90498-7
- Lilienfeld, 1990, Mortality from pulmonary embolism in the United States: 1962 to 1984, Chest, 98, 1067, 10.1378/chest.98.5.1067 · doi:10.1378/chest.98.5.1067
- Morrell, 1968, The post-mortem incidence of pulmonary embolism in a hospital population, Br J Surg, 55, 347, 10.1002/bjs.1800550506 · doi:10.1002/bjs.1800550506
- Uhland, 1964, Pulmonary embolism: a commonly missed clinical entity, Dis Chest, 45, 533, 10.1378/chest.45.5.533 · doi:10.1378/chest.45.5.533
- Goldhaber, 1982, Factors associated with correct antemortem diagnosis of major pulmonary embolism, Am J Med, 73, 822, 10.1016/0002-9343(82)90764-1 · DOI · Paper page
- Anderson, 1991, A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study, Arch Intern Med, 151, 933, 10.1001/archinte.1991.00400050081016 · DOI · Paper page
- Barritt, 1960, Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial, Lancet, 1, 1309, 10.1016/S0140-6736(60)92299-6 · DOI · Paper page
- Sasahara, 1983, Pulmonary thromboembolism: diagnosis and treatment, JAMA, 249, 2945, 10.1001/jama.1983.03330450075032 · doi:10.1001/jama.1983.03330450075032
- Hermann, 1961, Pulmonary embolism: a clinical and pathologic study with emphasis on the effect of prophylactic therapy with anticoagulants, Am J Surg, 102, 19, 10.1016/0002-9610(61)90680-8 · doi:10.1016/0002-9610(61)90680-8
- 1970, Urokinase Pulmonary Embolism Trial: phase 1 results—a cooperative study, JAMA, 214, 2163, 10.1001/jama.1970.03180120035007 · DOI · Paper page
- 1974, Urokinase-Streptokinase Embolism Trial: phase 2 results—a cooperative study, JAMA, 229, 1606, 10.1001/jama.1974.03230500024021 · DOI · Paper page
- Carson, 1992, The clinical course of pulmonary embolism, N Engl J Med, 326, 1240, 10.1056/NEJM199205073261902 · DOI · Paper page
- Ferrari, 1997, Clinical epidemiology of venous thromboembolic disease: results of a French multicentre registry, Eur Heart J, 18, 685, 10.1093/oxfordjournals.eurheartj.a015316 · doi:10.1093/oxfordjournals.eurheartj.a015316
- Lund, 1987, Pulmonary embolism: long-term follow-up after treatment with full-dose heparin, streptokinase or embolectomy, Acta Med Scand, 221, 61, 10.1111/j.0954-6820.1987.tb01246.x · doi:10.1111/j.0954-6820.1987.tb01246.x
- Alpert, 1976, Mortality in patients treated for pulmonary embolism, JAMA, 236, 1477, 10.1001/jama.1976.03270140029017 · DOI · Paper page
- Dalla-Volta, 1992, PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism: Plasminogen Activator Italian Multicenter Study 2, J Am Coll Cardiol, 20, 520, 10.1016/0735-1097(92)90002-5 · DOI · Paper page
- Goldhaber, 1993, Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion, Lancet, 341, 507, 10.1016/0140-6736(93)90274-K · DOI · Paper page
- Kasper, 1997, Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry, J Am Coll Cardiol, 30, 1165, 10.1016/S0735-1097(97)00319-7 · DOI · Paper page
- Konstantinides, 1997, Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry, Circulation, 96, 882, 10.1161/01.CIR.96.3.882 · DOI · Paper page
- Monreal, 1989, Recurrent pulmonary embolism: a prospective study, Chest, 95, 976, 10.1378/chest.95.5.976 · doi:10.1378/chest.95.5.976
- Paraskos, 1973, Late prognosis of acute pulmonary embolism, N Engl J Med, 289, 55, 10.1056/NEJM197307122890201 · DOI · Paper page
- Phear, 1960, Pulmonary embolism: a study of late prognosis, Lancet, 2, 832, 10.1016/S0140-6736(60)91903-6 · doi:10.1016/s0140-6736(60)91903-6
- van Beek, 1997, The clinical course of patients with suspected pulmonary embolism, Arch Intern Med, 157, 2593, 10.1001/archinte.1997.00440430075009 · doi:10.1001/archinte.1997.00440430075009
- Wheeler, 1988, Physician practices in the treatment of pulmonary embolism and deep vein thrombosis, Arch Intern Med, 148, 1321, 10.1001/archinte.1988.00380060085018 · DOI
- Walker, 1970, Resolution of pulmonary embolism, BMJ, 4, 135, 10.1136/bmj.4.5728.135 · doi:10.1136/bmj.4.5728.135
- Goldhaber, 1995, The international cooperative pulmonary embolism registry, Chest, 108, 302, 10.1378/chest.108.2.302 · doi:10.1378/chest.108.2.302
- Girard, 1987, Recurrence of pulmonary embolism during anticoagulant treatment: a prospective study, Thorax, 42, 481, 10.1136/thx.42.7.481 · DOI
- Dalen, 1969, Resolution rate of acute pulmonary embolism in man, N Engl J Med, 280, 1194, 10.1056/NEJM196905292802202 · doi:10.1056/nejm196905292802202
- Fred, 1966, Rapid resolution of pulmonary thromboemboli in man: angiographic study, JAMA, 196, 1137, 10.1001/jama.1966.03100260075021 · doi:10.1001/jama.1966.03100260075021
- Tow, 1967, Recovery of pulmonary arterial blood flow in patients with pulmonary embolism, N Engl J Med, 276, 1053, 10.1056/NEJM196705112761902 · doi:10.1056/nejm196705112761902
- Cook, 1995, Clinical recommendations using levels of evidence for antithrombotic agents, Chest, 108, 227S, 10.1378/chest.108.4_Supplement.227S · DOI · Paper page
- Sharma, 1982, Thrombolytic therapy, N Engl J Med, 306, 1268, 10.1056/NEJM198205273062105 · doi:10.1056/nejm198205273062105
- Marder, 1988, Thrombolytic therapy: current status, N Engl J Med, 318, 1512, 10.1056/NEJM198806093182306 · DOI · Paper page
- Loscalzo, 1990, An overview of thrombolytic agents, Chest, 97, 117S, 10.1378/chest.97.4_Supplement.117S · DOI
- Hyers, 1995, Antithrombotic therapy for venous thromboembolic disease, Chest, 108, 335S, 10.1378/chest.108.4_Supplement.335S · DOI
- Gulba, 1996, Thrombolytic agents: an overview, Ann Hematol, 73, S9
- Agnelli, 1992, Bolus thrombolysis in venous thromboembolism, Chest, 101, 172S, 10.1378/chest.101.4_Supplement.172S · DOI
- Agnelli, 1997, Rationale for the bolus administration of fibrin-specific thrombolytic agents, Fibrinolysis & Proteolysis, 11, 23, 10.1016/S0268-9499(97)80066-5 · doi:10.1016/s0268-9499(97)80066-5
- Agnelli, 1990, Rationale for bolus t-PA therapy to improve efficacy and safety, Chest, 97, 161S, 10.1378/chest.97.4_Supplement.161S · doi:10.1378/chest.97.4_supplement.161s
- Agnelli, 1997, Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism, Blood Coagul Fibrinolysis, 8, 216, 10.1097/00001721-199706000-00002 · doi:10.1097/00001721-199706000-00002
- Goldhaber, 1986, Acute pulmonary embolism treated with tissue plasminogen activator, Lancet, 2, 886, 10.1016/S0140-6736(86)90411-3 · doi:10.1016/s0140-6736(86)90411-3
- Goldhaber, 1988, Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism, Lancet, 2, 293, 10.1016/S0140-6736(88)92354-9 · DOI · Paper page
- Browse, 1964, Streptokinase and pulmonary embolism, Lancet, 11, 1039, 10.1016/S0140-6736(64)90991-2 · doi:10.1016/s0140-6736(64)90991-2
- Genton, 1968, Urokinase therapy in pulmonary thromboembolism, Am Heart J, 76, 628, 10.1016/0002-8703(68)90161-0 · doi:10.1016/0002-8703(68)90161-0
- Miller, 1969, Treatment of pulmonary embolism with streptokinase: a preliminary report, BMJ, 1, 812, 10.1136/bmj.1.5647.812 · doi:10.1136/bmj.1.5647.812
- Miller, 1971, Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism, BMJ, 2, 681, 10.1136/bmj.2.5763.681 · DOI · Paper page
- Sautter, 1967, Urokinase for the treatment of acute pulmonary thromboembolism, JAMA, 202, 215, 10.1001/jama.1967.03130160089019 · doi:10.1001/jama.1967.03130160089019
- Sasahara, 1967, Urokinase therapy in clinical pulmonary embolism: a new thrombolytic agent, N Engl J Med, 277, 1168, 10.1056/NEJM196711302772203 · doi:10.1056/nejm196711302772203
- Tow, 1967, Urokinase in pulmonary embolism, N Engl J Med, 277, 1161, 10.1056/NEJM196711302772202 · DOI
- Dickie, 1974, Hemodynamic effects of bolus infusion of urokinase in pulmonary thromboembolism, Am Rev Respir Dis, 109, 48
- Hirsh, 1968, Streptokinase therapy in acute major pulmonary embolism: effectiveness and problems, BMJ, 4, 729, 10.1136/bmj.4.5633.729 · doi:10.1136/bmj.4.5633.729
- Sharma, 1980, Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism, N Engl J Med, 303, 842, 10.1056/NEJM198010093031502 · DOI · Paper page
- Tibbutt, 1974, Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism, BMJ, 1, 343, 10.1136/bmj.1.5904.343 · DOI · Paper page
- Ly, 1978, A controlled trial of streptokinase and heparin in the treatment of major pulmonary embolism, Acta Med Scand, 203, 465, 10.1111/j.0954-6820.1978.tb14909.x · DOI · Paper page
- Marini, 1988, Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial, Respiration, 54, 162, 10.1159/000195517 · DOI
- PIOPED Investigators, 1990, Tissue plasminogen activator for the treatment of acute pulmonary embolism: a collaborative study by the PIOPED Investigators, Chest, 97, 528, 10.1378/chest.97.3.528 · DOI · Paper page
- Levine, 1990, A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism, Chest, 98, 1473, 10.1378/chest.98.6.1473 · DOI · Paper page
- Jerjes-Sanchez, 1995, Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial, J Thromb Thrombolysis, 2, 227, 10.1007/BF01062714 · DOI · Paper page
- Sharma, 1990, Long-term hemodynamic benefit of thrombolytic therapy in pulmonary embolic disease [abstract], J Am Coll Cardiol, 15, 65A, 10.1016/0735-1097(90)91976-2 · doi:10.1016/0735-1097(90)91976-2
- Meyer, 1992, Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial, J Am Coll Cardiol, 19, 239, 10.1016/0735-1097(92)90472-Y · DOI · Paper page
- Goldhaber, 1992, Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial, J Am Coll Cardiol, 20, 24, 10.1016/0735-1097(92)90132-7 · DOI · Paper page
- Meneveau, 1997, Streptokinase vs alteplase in massive pulmonary embolism: a randomized trial assessing right heart hemodynamics and pulmonary vascular obstruction, Eur Heart J, 18, 1141, 10.1093/oxfordjournals.eurheartj.a015410 · DOI
- Meneveau, 1998, Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up, J Am Coll Cardiol, 31, 1057, 10.1016/S0735-1097(98)00068-0 · DOI · Paper page
- Tapson, 1992, Rapid thrombolysis of massive pulmonary emboli without systemic fibrinogenolysis: intraembolic infusion of thrombolytic therapy [abstract], Am Rev Respir Dis, 145, A719
- Schwarz, 1985, Sustained improvement of pulmonary hemodynamics in patients at rest and during exercise after thrombolytic treatment of massive pulmonary embolism, Circulation, 71, 117, 10.1161/01.CIR.71.1.117 · doi:10.1161/01.cir.71.1.117
- Petitpretz, 1984, Effects of a single bolus of urokinase in patients with life-threatening pulmonary emboli: a descriptive trial, Circulation, 70, 861, 10.1161/01.CIR.70.5.861 · doi:10.1161/01.cir.70.5.861
- Vujic, 1983, Massive pulmonary embolism: treatment with full heparinization and topical low-dose streptokinase, Radiology, 148, 671, 10.1148/radiology.148.3.6878682 · doi:10.1148/radiology.148.3.6878682
- Leeper, 1988, Treatment of massive acute pulmonary embolism: the use of low doses of intrapulmonary arterial streptokinase combined with full doses of systemic heparin, Chest, 93, 234, 10.1378/chest.93.2.234 · doi:10.1378/chest.93.2.234
- Gallus, 1975, Thrombolysis with a combination of small doses of streptokinase and full doses of heparin, Semin Thromb & Hemost, 2, 14, 10.1055/s-0028-1086112 · doi:10.1055/s-0028-1086112
- Edwards, 1973, Low-dose urokinase in major pulmonary embolism, Lancet, 2, 409, 10.1016/S0140-6736(73)92273-3 · doi:10.1016/s0140-6736(73)92273-3
- Barberena, 1983, Intraarterial infusion of urokinase in the treatment of acute pulmonary thromboembolism: preliminary observations, AJR Am J Roentgenol, 140, 883, 10.2214/ajr.140.5.883 · doi:10.2214/ajr.140.5.883
- Verstraete, 1988, Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism, Circulation, 77, 353, 10.1161/01.CIR.77.2.353 · DOI · Paper page
- Fava, 1997, Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism, J Vasc Interv Radiol, 8, 261, 10.1016/S1051-0443(97)70552-9 · DOI
- Stern, 1988, Urokinase versus tissue plasminogen activator in pulmonary embolism, Lancet, 2, 691
- Diehl, 1992, Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism, Am J Cardiol, 70, 1477, 10.1016/0002-9149(92)90302-F · doi:10.1016/0002-9149(92)90302-f
- Goldhaber, 1994, Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis: an international multicenter randomized trial, Chest, 106, 718, 10.1378/chest.106.3.718 · DOI · Paper page
- Goldhaber, 1994, Two trials of reduced bolus alteplase in the treatment of pulmonary embolism: an overview, Chest, 106, 725, 10.1378/chest.106.3.725 · doi:10.1378/chest.106.3.725
- Sors, 1994, Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism: a randomized controlled multicenter trial, Chest, 106, 712, 10.1378/chest.106.3.712 · DOI · Paper page
- Palla, 1997, Resolution of pulmonary embolism: effect of therapy and putative age of emboli, Respiration, 64, 50, 10.1159/000196642 · doi:10.1159/000196642
- Daniels, 1997, Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism, Am J Cardiol, 80, 184, 10.1016/S0002-9149(97)00315-9 · DOI · Paper page
- Levine, 1995, Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism, Chest, 108, 291S, 10.1378/chest.108.4_Supplement.291S · DOI
- Kanter, 1997, Thrombolytic therapy for pulmonary embolism: frequency of intracranial hemorrhage and associated risk factors, Chest, 111, 1241, 10.1378/chest.111.5.1241 · DOI · Paper page
- Lualdi, 1995, Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications, Am Heart J, 130, 1276, 10.1016/0002-8703(95)90155-8 · DOI · Paper page
- Goldhaber, 1997, Pulmonary embolism thrombolysis: broadening the paradigm for its administration, Circulation, 96, 716, 10.1161/01.CIR.96.3.716 · doi:10.1161/01.cir.96.3.716
- Goldhaber, 1995, Thrombolytic therapy in venous thromboembolism: clinical trials and current indications, Clin Chest Med, 16, 307, 10.1016/S0272-5231(21)01094-7 · DOI
- 1996, Opinions regarding the diagnosis and management of venous thromboembolic disease: ACCP Consensus Committee on Pulmonary Embolism, Chest, 109, 233, 10.1378/chest.109.1.233 · doi:10.1378/chest.109.1.233
- Goodman, 1995, Detection of pulmonary embolism in patients with unresolved clinical and scintigraphic diagnosis: helical CT versus angiography, AJR Am J Roentgenol, 164, 1369, 10.2214/ajr.164.6.7754875 · doi:10.2214/ajr.164.6.7754875
- Remy-Jardin, 1996, Diagnosis of pulmonary embolism with spiral CT: comparison with pulmonary angiography and scintigraphy, Radiology, 200, 699, 10.1148/radiology.200.3.8756918 · doi:10.1148/radiology.200.3.8756918
- van Rossum, 1996, Pulmonary embolism: validation of spiral CT angiography in 149 patients, Radiology, 201, 467, 10.1148/radiology.201.2.8888242 · doi:10.1148/radiology.201.2.8888242
- van Rossum, 1996, Role of spiral volumetric computed tomographic scanning in the assessment of patients with clinical suspicion of pulmonary embolism and an abnormal ventilation/perfusion scan, Thorax, 51, 23, 10.1136/thx.51.1.23 · doi:10.1136/thx.51.1.23
- Gefter, 1995, Pulmonary thromboembolism: recent developments in diagnosis with CT and MR imaging, Radiology, 197, 561, 10.1148/radiology.197.3.7480717 · doi:10.1148/radiology.197.3.7480717
- Blum, 1994, Spiral-computed tomography versus pulmonary angiography in the diagnosis of acute massive pulmonary embolism, Am J Cardiol, 74, 96, 10.1016/0002-9149(94)90502-9 · doi:10.1016/0002-9149(94)90502-9
- Kasper, 1986, Echocardiographic findings in patients with proved pulmonary embolism, Am Heart J, 112, 1284, 10.1016/0002-8703(86)90361-3 · doi:10.1016/0002-8703(86)90361-3
- Jardin, 1987, Quantitative two-dimensional echocardiography in massive pulmonary embolism: emphasis on ventricular interdependence and leftward septal displacement, J Am Coll Cardiol, 10, 1201, 10.1016/S0735-1097(87)80119-5 · DOI · Paper page
- Come, 1987, Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator, J Am Coll Cardiol, 10, 971, 10.1016/S0735-1097(87)80333-9 · doi:10.1016/s0735-1097(87)80333-9
- Come, 1992, Echocardiographic evaluation of pulmonary embolism and its response to therapeutic interventions, Chest, 101, 151S, 10.1378/chest.101.4_Supplement.151S · doi:10.1378/chest.101.4_supplement.151s
- McConnell, 1996, Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism, Am J Cardiol, 78, 469, 10.1016/S0002-9149(96)00339-6 · DOI · Paper page
- 1980, Thrombolytic therapy in thrombosis: a National Institutes of Health consensus development conference, Ann Intern Med, 93, 141, 10.7326/0003-4819-93-1-141 · DOI · Paper page
- Goldhaber, 1995, Contemporary pulmonary embolism thrombolysis, Chest, 107, 45S, 10.1378/chest.107.1_Supplement.45S · DOI
- Goldhaber, 1991, Recent advances in the diagnosis and lytic therapy of pulmonary embolism, Chest, 99, 173S, 10.1378/chest.99.4.173S · doi:10.1378/chest.99.4.173s
Cited by
Ortel, T. L., Neumann, I., Ageno, W., Beyth, R., Clark, N. P., Cuker, A., Hutten, B. A., Jaff, M. R., Manja, V., Schulman, S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001830 · Cited by 1,489
Wood, K. E. (2002) · Chest · doi:10.1378/chest.121.3.877 · Cited by 718
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism
(2003) · Thorax · doi:10.1136/thorax.58.6.470 · Cited by 686
Wan, S., Quinlan, D. J., Agnelli, G., & Eikelboom, J. W. (2004) · Circulation · doi:10.1161/01.cir.0000137826.09715.9c · Cited by 616
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism
Campbell, I. A., Fennerty, A., & Miller, A. C. (2005) · PULMONOLOGIYA · doi:10.18093/0869-0189-2005-0-4-19-39 · Cited by 458
Metadata
- Authors
- Arcasoy, S. M., & Kreit, J. W.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 1999-06
- Volume
- 115
- Issue
- 6
- Pages
- 1695-1707
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2103326534
- Cited by
- 223
- References
- 0
- FWCI
- 13.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 6420 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thrombolytic Therapy of Pulmonary Embolism. https://app.cochat.ai/papers/10.1378/chest.115.6.1695
- The paper
- Arcasoy, S. M., & Kreit, J. W. (1999). Thrombolytic Therapy of Pulmonary Embolism. Chest. https://doi.org/10.1378/chest.115.6.1695
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.